The company recently delivered some exciting trial data, but it also needs to deliver in the second part of the trial.
I once heard a story from a therapist at a convalescent rehabilitation ward.“The day of discharge is the saddest. There are ...
Hello, and welcome to the Duvakitug IBD Ph2b Maintenance Topline Results Conference Call. My name is Alex, and I'll be coordinating today's call. [Operator Instructions] I'll now hand it over to Chris ...
Viking Therapeutics is advancing VK2735 for obesity and diabetes, with key maintenance study data expected in Q3 '26. Learn why VKTX stock is a hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results